Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion

Trial Profile

Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2018

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Retinal oedema; Retinal vein occlusion
  • Focus Registrational; Therapeutic Use
  • Acronyms RVO3
  • Sponsors Allergan
  • Most Recent Events

    • 01 Jan 2018 Primary endpoint of Number of Patients With 15 or More Letter Improvement in Best Corrected Visual Acuity in the Study Eye has been met, according to results published in the Graefes Archive for Clinical and Experimental Ophthalmology.
    • 01 Jan 2018 Results published in the Graefes Archive for Clinical and Experimental Ophthalmology
    • 21 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top